Form 4 for DGX Quest Diagnostics
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001022079-23-000066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-08 | 2023-03-06 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - Grant | $147.86 | +1,985 | 11.8K | +20% | +$293.5K | |
| 2023-03-08 | 2023-03-06 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F - Tax | $147.86 | -583 | 11.2K | -5% | -$86.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | A | A | 1,985 | $147.86 | 11,824 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-06 | F | D | 583 | $147.86 | 11,241 | D | — | — | (F3) The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. |